Our commitment to quality is intrinsic to our organization, from the leadership of senior management to the dedication of individual contributors.
We have developed strong, collaborative relationships with our technology vendors, which helps us adopt the right approach for your study. These technology partnerships provide us with direct information about product enhancements and new functionality, enabling us to anticipate future rollouts and incorporate them smoothly as early adopters. Allucent makes significant investments in training with platform providers and staff certification, giving you confidence in your partnership with our expert team.
We pride ourselves on our nimble approach and the personal level of support we bring to your project. At the same time, you have access to our extensive breadth of knowledge and global resources.
Cloud-Based EDC Systems (EDC programming/technology)
We carefully select cloud-based EDC systems for their user-friendly interface, additional modular options, real-time data capture, and reporting and information dashboards. All of our EDC systems are regulatory and 21 CFR Part 11–compliant.
Our data management team will assist you in making the right decision based on your study-specific requirements and preferences. While we often recommend using an in-house preferred EDC platform, our team can also support the management and execution of your trial if you choose an alternative. Powered by best-in-class technology, Allucent is certified to build EDC systems in Merative Clinical Development, Medidata RAVE, and other industry-leading platforms. Our data management team supports: *
- Merative Clinical Development (previously IBM Clinical Development)
- Medidata RAVE
- Other sponsor-requested platforms
Reporting, Insights, and Analytics
Combining our clinical data management services with industry-leading technology, we give you on-time, on-demand reporting and in-depth insight into your trial. You will have 24/7 access to the systems where you can utilize advanced data integration and dynamic dashboards to see the status of your trial.
Making evidence-based decisions is critical to the success or failure of your study. At Allucent, we offer you an exceptional team combined with the best technology to support your study needs. Our experienced data scientists and clinical programmers delve deep into your data to provide you with additional insights.
We maintain a global library of data standards according to CDISC requirements, industry standards, and best practices. With the CDASH-compliant global library, our goal is to streamline processes from database design to setting up analytic dashboards and generation of SDTM/ADaM datasets by emphasizing quality, time savings, and cost efficiencies within our biometrics unit.
Insights and analytics: Allucent offers insights and analytics reporting at regular intervals during the trial to be used for the thorough review of data. The reports are to be seen as snapshots of the data while the trial is ongoing. They summarize current trial data including safety, biomarker read-outs, and preliminary efficacy trends.
This will aid in decision-making for DMCs/DSMBs/SRCs, protocol amendments, decisions on consecutive study designs, and future development plans, among others. The concise and ready-to-present format of our insights and analytics reports will help you to present important trend data to your internal management teams, board of directors, and investors. In addition, the reports can be used to generate abstracts, posters, or oral presentations at scientific conferences.
Risk-based monitoring support: Allucent’s data management team is highly involved in identifying data points that require Source Data Verification (SDV) during the eCRF design process and setting the parameter in EDC system accordingly. Further, the data review and validation plan can be built around the SDV items. Customized reports can also be developed by using our insights and analytics tools.